Porcine model of progressive cardiac hypertrophy and fibrosis with secondary postcapillary pulmonary hypertension
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Porcine model of progressive cardiac hypertrophy and fibrosis with secondary postcapillary pulmonary hypertension
Authors
Keywords
Cardiac hypertrophy, PET-MRI imaging, Aortic isthmus stenosis, Translational large animal model, Gene expression
Journal
Journal of Translational Medicine
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-10-06
DOI
10.1186/s12967-017-1299-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myocardial fibrosis: biomedical research from bench to bedside
- (2017) Mariann Gyöngyösi et al. EUROPEAN JOURNAL OF HEART FAILURE
- Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic‐Banded Mini‐Swine
- (2016) Jessica A. Hiemstra et al. Journal of the American Heart Association
- Myocardial ATP hydrolysis rates in vivo: a porcine model of pressure overload-induced hypertrophy
- (2015) Qiang Xiong et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction
- (2015) Michael Schwarzl et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Left Ventricular Ejection Fraction (EF) of 55% as Cutoff for Late Transition From Heart Failure (HF) With Preserved EF to HF With Mildly Reduced EF
- (2015) Tomoya Ueda et al. CIRCULATION JOURNAL
- Long-Term Effects of AAV1/SERCA2a Gene Transfer in Patients With Severe Heart Failure
- (2013) Krisztina Zsebo et al. CIRCULATION RESEARCH
- Cardiac SERCA2A/B: Therapeutic targets for heart failure
- (2013) Mohammad Abrar Shareef et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Circulating miR-29a, Among Other Up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients With Hypertrophic Cardiomyopathy
- (2013) Roberta Roncarati et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- miRBase: annotating high confidence microRNAs using deep sequencing data
- (2013) Ana Kozomara et al. NUCLEIC ACIDS RESEARCH
- Therapeutic Cardiac‐Targeted Delivery of miR‐1 Reverses Pressure Overload–Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling
- (2013) Ioannis Karakikes et al. Journal of the American Heart Association
- Progressive induction of left ventricular pressure overload in a large animal model elicits myocardial remodeling and a unique matrix signature
- (2011) William M. Yarbrough et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Is mitral E/E' ratio a reliable predictor of left ventricular diastolic pressures in patients without heart failure?
- (2011) M. Previtali et al. European Heart Journal-Cardiovascular Imaging
- Role of microRNAs in cardiac hypertrophy, myocardial fibrosis and heart failure
- (2011) De-li Dong et al. Acta Pharmaceutica Sinica B
- Heart failure and mouse models
- (2010) R. Breckenridge Disease Models & Mechanisms
- The role of inflammatory and fibrogenic pathways in heart failure associated with aging
- (2010) Wei Chen et al. HEART FAILURE REVIEWS
- Epidemiology and risk profile of heart failure
- (2010) Anh L. Bui et al. Nature Reviews Cardiology
- 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
- (2009) et al. CIRCULATION
- Small Animal Models of Heart Failure
- (2009) Richard D. Patten et al. Circulation-Heart Failure
- A model for left ventricular hypertrophy enabling non-invasive assessment of cardiac function
- (2009) Søren Lunde et al. SCANDINAVIAN CARDIOVASCULAR JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started